Contacts: Anthony G. Viscogliosi, Viscogliosi Bros., LLC (212) 583-9700
Chris Storer, Creative Partners (203) 705-9219
SMALL BONE INNOVATIONS, LLC EXPANDS PRODUCT PORTFOLIO WITH VB’S
ACQUISITION OF FIXANO, S.A.
New York, NY: May 4, 2005 - Small Bone Innovations, LLC (SBI), a Viscogliosi
Bros., LLC (VB) portfolio company, expanded its product line of orthopedic
devices with VB’s acquisition of Fixano S.A., Bourg-en-Bresse,
France, a leading international developer and manufacturer of orthopedic
devices. Terms were not disclosed.
SBI was formed in May 2004 and launched at the American Academy of Orthopaedic
Surgeons (AAOS) Annual Meeting in February 2005 by Anthony, John and
Marc Viscogliosi, Principals of VB, to develop and acquire technologies
in the small bone & joint sector. In 2004, VB acquired Avanta Orthopaedics,
Inc. and Envision Manufacturing, Inc., as well as worldwide licensing
rights to market Biorthex, Inc.’s Actipore™ and Artimplant,
AB’s Artelon® CMC-1 Spacer, two promising tissue technologies.
In 2005, in addition to Fixano, SBI also acquired Xtremi-T, LLC.
Fixano, established in 1987, manufactures and distributes worldwide
a range of innovative devices and instrumentation for surgical repair
of disease or traumatic injury to the bones and joints. This includes:
spine arthroplasty and spine fusion systems; internal and external fixation
systems for the fingers, hand, wrist, elbow; shoulder systems; foot,
small bone and long bone trauma products. Devices and systems that target
bones from the fingers to the shoulder and from the toe to the mid-calf
will become products marketed by SBI.
Fixano’s offices and manufacturing facility in Bourg-en-Bresse
will serve as the international operating headquarters of SBI.
Fixano’s President, Jean Jacques Martin joins SBI as VP, International,
responsible for outside U.S. sales, marketing, manufacturing and product
development. Mr. Martin said: “SBI’s spectrum of arthroplasty,
fixation, trauma, biologic solutions and tissue technologies is rapidly
achieving industry leadership. The company is also expanding its new
product pipeline with more than 10 new implant and instrument systems
planned for introduction within the next 12 months to further augment
these offerings. Our goal is to give surgeons and their patients the
widest choice of proven treatment options.”
President & COO of SBI, Michael Simpson, said: “We are delighted
to have secured the excellent range of Fixano products for small bone
and joint repair. Furthermore, Mr. Martin provides us with outstanding
leadership in the rapidly growing European market.”
Anthony G. Viscogliosi, Chairman & CEO of SBI and Principal of VB,
said: “Completing the acquisition of Fixano is a major landmark
in our strategy to accumulate a superior portfolio of truly life-changing
technologies designed to provide patients with permanent solutions to
osteo and rheumatoid arthritis and for traumatic injury to the small
bone & joint anatomy. Also, as an established presence in the rapidly
growing European market, Fixano offers access to many highly regarded
orthopedic surgeons who are committed to developing the kind of products
needed to seize opportunities in the small bone and joint sector that
are not being developed by the major orthopedic companies.”
Small Bone Innovations, LLC (SBI) was founded in 2004 by Viscogliosi
Bros. LLC., (VB), the New York-based merchant banking firm that specializes
in the musculoskeletal /orthopedic sector. VB created SBI as the first
company to focus purely on small bone & joint science. By integrating
established companies and professionals in the field, SBI today offers
a broad , clinically proven portfolio of products and technology to
treat trauma and diseases in small bones & joints.
VB’s acquisitions and technology licenses include: Avanta
Orthopaedics (hand/wrist/elbow arthroplasty and trauma products
– USA); Envision (implant manufacturing –
USA); Actipore™ (porous metal technology –
Canada); Artelon ®(biologically active & biodegradable
technology – Sweden); Xtremi-T (resorbable trauma
technology – USA).
For more information on SBI visit: www.totalsmallbone.com
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, VB was the first venture capital/private
equity and merchant banking firm dedicated to the musculoskeletal/orthopedics
sector of the health care industry. Today, VB is a leading independent
firm with a mission to create, build and finance companies founded on
innovations developed by surgeons and uniquely focused on "life
changing" musculoskeletal/orthopedic technologies. VB has worldwide
surgeon, industry and trade relationships and significant financial
expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total
of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics
sector. They have pioneered innovative financial, strategic and management
initiatives for companies in the sector, from start-up, seed and development
stage all the way to exit, while helping thousands of people lead better
lives through the orthopedic and spinal products marketed and sold by
the companies they have assisted in developing and financing.
> Back to Press Releases